Companies: 10,795·Total market cap: $144.5T
Bayer AG

Bayer AG

BAYRYOTCHealthcare● Active
$10.25
$-0.05(-0.46%)
Market Cap$40.3B
P/E Ratio
52W High$14.85
52W Low$7.19

Bayer AG (BAYRY) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

BAYRY · free cash flow · updated Jun 8, 2026

Core FCF metrics

Free cash flow was $2.00B for FY2025 (fiscal year ending 2025-12-31), down 56.4% year-over-year The FCF margin was 4.6%. Five-year CAGR stands at -4.2%.

FY2025 Free Cash Flow$2.00B▼ -56.4% YoY
Trailing 12M (TTM)$1.63Btrailing 4 quarters sum
FCF Margin4.6%$2.00B ÷ revenue
3-Year CAGR-21.5%FY2022 → FY2025
5-Year CAGR-4.2%FY2020 → FY2025
FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

Positive FCFNegative FCF
Free Cash Flow
YoY Growth %
bayry free cash flow history · bayry free cash flow chart · bayry free cash flow growth rate · bayry free cash flow last 10 years

Annual free cash flow data

Fiscal YearFree Cash FlowYoY ChangeFCF Margin
FY2025Latest$2.00B▼ 56.4%4.6%
FY2024$4.59B▲ +94.0%9.8%
FY2023$2.37B▼ 42.9%5.0%
FY2022$4.14B▲ +67.2%8.2%
FY2021$2.48B▼ 0.3%5.6%
FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP
bayry free cash flow 2025 · bayry free cash flow 2024 · bayry free cash flow 2023 · bayry operating cash flow

FCF valuation metrics

Bayer AG (BAYRY) trades at a FCF yield of 5.76% and a price-to-free-cash-flow ratio of 24.4x. FCF per share stands at $0.42, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)
5.76%
Free Cash Flow ÷ Market Cap
per FMP freeCashFlowYieldTTM definition
FCF per Share (TTM)
$0.42
TTM FCF ÷ Shares Outstanding
Price / FCF
x24.4
Share Price ÷ FCF per Share
EV / FCF (TTM)
x33.8
Enterprise Value basis
Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31
bayry price to free cash flow · bayry free cash flow yield · bayry free cash flow per share · bayry price to cash flow ratio

Cash flow statement summary

For FY2025, Bayer AG generated $4.39B in operating cash flow and spent 2.39B in capital expenditures, yielding $2.00B in free cash flow.

Operating Activities
+$4.39B
Cash from core business operations
2025-12-31
Investing Activities
−$1.55B
CapEx, acquisitions & investments
2025-12-31
Financing Activities
−$2.10B
Buybacks, dividends & debt
2025-12-31
FCF FormulaOperating CF ($4.39B) − |CapEx| (2.39B) = FCF ($2.00B)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement
bayry cash flow statement · bayry cash flow statement 2025 · bayry operating cash flow · bayry cash flow from operations

Free cash flow vs peers (Healthcare)

#CompanyFree Cash FlowYoY
#1
Bayer AG
Bayer AGYOU
BAYRY
$2.00B-56.4%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$19.70B-0.7%
#3
AbbVie Inc.
AbbVie Inc.
ABBV
$17.82B-0.1%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$16.07B-22.4%
#5
Eli Lilly and Company
Eli Lilly and Company
LLY
$8.97B+2065.6%
Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Bayer AG (BAYRY) reported free cash flow of $2.00B for FY2025 (fiscal year ending 2025-12-31), down 56.4% year-over-year. The FCF margin was 4.6%.

Based on available data, Bayer AG has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $6.51B in FY2016. The 5-year CAGR stands at -4.2%.

Bayer AG's FCF yield is 5.76% and price-to-FCF ratio is 24.4x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Frequently asked questions

BAYRY free cash flow · 8 questions

Bayer AG free cash flow was $2.00B for FY2025, down 56.4% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $1.63B.

BAYRY free cash flowBAYRY FCFBAYRY FCF 2025BAYRY free cash flow TTM

Source: FMP /cash-flow-statement · US GAAP · Bayer AG · Bayer AG SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026